Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending May 2013. The report documents the outcome of the Annual General Meeting held on May 1, 2013, where all proposed special resolutions were duly passed.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document serves as a procedural report regarding corporate governance resolutions rather than a financial performance statement.
Material Changes
No material financial changes versus the prior comparable period are disclosed in this text. The primary event reported is the successful passage of special resolutions at the Annual General Meeting.
Guidance, Outlook, and Risks
The filing contains no management commentary, financial guidance, outlook, or discussion of risks and contingencies. It confirms that copies of the passed resolutions have been filed with the UK Listing Authority National Storage Mechanism and are available for inspection.
Investor Verification Points
- Verify the specific content of the special resolutions passed on May 1, 2013, via the UK Listing Authority National Storage Mechanism.
- Confirm the availability of the resolutions at the referenced Hemscott website.
- Note that this filing does not contain financial data; refer to the company's Form 20-F or interim financial reports for performance metrics.